Clinical Trials | December 31, 2025
GenSight Biologics gets early access nod for candidate gene therapy in Israel
Applications include detailed scientific rationale and supporting clinical evidence
Applications include detailed scientific rationale and supporting clinical evidence
The partnership also sets the stage for broader collaboration on rare disease treatments
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
Angelini Ventures has already invested €125 million in 22 startups
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
Winlevi is authorized in EU for the treatment of acne vulgaris
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Subscribe To Our Newsletter & Stay Updated
